Antimicrobial Resistance Patterns of Bacterial Isolates From Urine Samples in Selected Tertiary Hospitals in Addis Ababa, Ethiopia

Why It Matters

The high prevalence of multidrug‑resistant uropathogens threatens effective UTI treatment in Ethiopia, raising costs and risking treatment failures. Strengthening stewardship and local susceptibility data is essential to preserve last‑line antibiotics and protect public health.

Key Takeaways

• E. coli caused 35% of positive urine cultures.
• 60% of isolates were multidrug‑resistant.
• Amoxicillin resistance exceeded 80% among uropathogens.
• Meropenem retained ~80% susceptibility.
• No link found between MDR and patient age or gender.

Pulse Analysis

Urinary tract infections remain one of the most common bacterial ailments worldwide, and the rise of antimicrobial resistance (AMR) is eroding the efficacy of standard therapies. In low‑ and middle‑income settings like Ethiopia, limited laboratory capacity often hampers real‑time surveillance, leaving clinicians to rely on outdated guidelines. This study provides a crucial snapshot of current resistance patterns in Addis Ababa’s tertiary hospitals, highlighting how rapidly uropathogens are outpacing first‑line drugs such as amoxicillin and third‑generation cephalosporins. By quantifying resistance rates, the research underscores the urgency of updating empirical treatment protocols to reflect local microbiology.

The data reveal that gram‑negative organisms, particularly E. coli and Klebsiella spp., dominate urinary isolates, with more than three‑quarters resistant to commonly prescribed agents. Notably, carbapenems (meropenem) and aminoglycosides (amikacin) maintain relatively high activity, offering viable options for complicated infections. However, the steep 60% multidrug‑resistance (MDR) prevalence signals that even these back‑line drugs could become compromised without intervention. The lack of a statistically significant link between MDR and demographic factors suggests that resistance is driven more by prescribing habits and infection control practices than by patient characteristics.

The findings compel health authorities to prioritize antimicrobial stewardship programs, integrating routine susceptibility testing into clinical workflows and educating prescribers on judicious antibiotic use. Establishing a national AMR surveillance network would enable timely data sharing, facilitating evidence‑based updates to treatment guidelines. Moreover, investment in infection prevention—such as catheter care protocols—can reduce UTI incidence and curb the spread of resistant strains. As Ethiopia confronts a growing AMR burden, proactive policies will be pivotal in safeguarding the efficacy of life‑saving antibiotics for future generations.